Adaptive Phage Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Adaptive Phage Therapeutics's estimated annual revenue is currently $2.4M per year.
- Adaptive Phage Therapeutics received $41 in venture funding in May 2021.
- Adaptive Phage Therapeutics's estimated revenue per employee is $77,500
- Adaptive Phage Therapeutics's total funding is $78M.
Employee Data
- Adaptive Phage Therapeutics has 31 Employees.
- Adaptive Phage Therapeutics grew their employee count by -44% last year.
Adaptive Phage Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Head Project Management | Reveal Email/Phone |
3 | Director, Quality | Reveal Email/Phone |
4 | Director, Clinical Program Management | Reveal Email/Phone |
5 | Senior Director HR Business Partner | Reveal Email/Phone |
6 | Director, Product Development | Reveal Email/Phone |
7 | Associate Director, Quality | Reveal Email/Phone |
8 | Chief Medical Officer | Reveal Email/Phone |
9 | Associate Director, HR & Administration | Reveal Email/Phone |
10 | Manager, Manufacturing Operations | Reveal Email/Phone |
Adaptive Phage Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 2 | 0% | N/A | N/A |
#2 | $3.6M | 46 | -31% | $17.5M | N/A |
#3 | $3.6M | 46 | -34% | $10.5M | N/A |
#4 | $30.2M | 156 | 0% | $69.4M | N/A |
#5 | $11.8M | 76 | -15% | N/A | N/A |
#6 | $1.7M | 11 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $8.8M | 57 | 19% | N/A | N/A |
#9 | $0.2M | 1 | -86% | N/A | N/A |
#10 | $2M | 13 | 18% | N/A | N/A |
What Is Adaptive Phage Therapeutics?
Adaptive Phage Therapeutics, Inc. (APT) is a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. Two key components of APT's approach are 1) PhageBank™, a large and dynamically growing collection of bacteriophages or “phages†(viruses that attack specific targeted bacteria) and 2) an innovative rapid system for matching phage to patient-specific bacterial infections. In 2016 APT's approach achieved its first in-human success with the rescue of a critically ill MDR infected patent.
keywords:N/A
$78M
Total Funding
31
Number of Employees
$2.4M
Revenue (est)
-44%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Adaptive Phage Therapeutics News
Funding will be used to accelerate clinical trials against Prosthetic Joint Infection (PJI) and Diabetic Foot Osteomyelitis (DFO) -...
Adaptive Phage Therapeutics, Inc., a Gaithersburg, MD-based clinical-stage biotechnology company dedicated to providing therapies to treat...
Gaithersburg's Adaptive Phage Therapeutics Inc. has raised ... year after securing nearly $41 million to advance its therapy for superbugs.
Other Companies in Gaithersburg
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.6M | 31 | 48% | N/A |
#2 | $5M | 32 | 33% | $75M |
#3 | $3.8M | 32 | 3% | N/A |
#4 | $7.5M | 32 | -36% | N/A |
#5 | $6.2M | 32 | 0% | N/A |
Adaptive Phage Therapeutics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2021-05-07 | $41 | B | Deerfield Management | Article |